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Introduction
Breast cancer (BC) is a malignant neoplasm
arising from mammary glands and is a rare entity in
the male patient (European prevalence: 1/100000)(1).
The Surveillance, Epidemiology, and End Results
(SEER) registry contains a total of 5,494 cases of
male breast cancer (MBC) and 835,000 cases of
female breast cancer (FBC) diagnosed from 1973
through 2005(2). Genes that have been implicated in
the etiology of MBC include BRCA 1-2(3) AR gene,
cytochrome P45017 (CYP17), the XXY karyotype
(Klinefelter syndrome), the PTEN tumor suppressor
gene associated with Cowden syndrome, and the
CHEK2 gene(4). An effective role of HLA system in
the pathogenesis has not been still clarified as in
other malignancies(5-6). In addition to the genetic
factors associated with an increased risk of  MBC,
several epidemiologic risk factors have been inves-
tigated, including disorders associated with elevat-
ed estrogen levels, testicular disorders, benign
breast conditions (e.g., gynecomastia), occupational
and environmental exposures, and dietary factors.
Several malignancies tend to metastasize to the
bones and the spine is a common site for skeletal
metastases(7, 8, 9).
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ABSTRACT
Introduction: Breast cancer is a malignant neoplasm arising from mammary glands and is a rare entity in the male patient.
Spine is a common site for skeletal metastases.
Case presentation: A 53-years-old male was admitted to our Neurosurgical unit because of an untreatable dorsal pain. He had
been treated 3 years before for breast cancer. A dorsal Magnetic Resonance Imaging (MRI) evidenced pathological masses at T8
level. A total body Computed Tomography (CT) scan revealed lungs and liver metastases. After a multidisciplinary consult, a poste-
rior T8 decompression, a radiofrequency thermoablation in T8 vertebral body followed by screws and rods fixation (T7-T9) was
performed. Post-operative course was uneventful and the patient experienced a significant improvement of dorsal pain. Cycles of
adjuvant chemo-radiotherapy followed. After 8 months, patient is still alive and in good general conditions but a spine MRI revealed
a rapid and widespread diffusion of ostelytic metastases. 
Conclusion: Despite the high incidence of breast cancer metastases to the spine, very few clinical reports (just eight, whose
only one treated surgically) in the literature deal specifically with metastases from male breast cancer, which is rarer and with a
worst prognosis than female counterpart. In spite of the poor course, surgery still plays a role in treating these kind of malignancies
and in improving quality of life.
Keywords: male breast cancer, therapy, metastatic breast cancer, dorsal vertebral metastatic, surgery.
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In the whole breast cancer population, one out
of three patients presents recurrence within 10
years; furthermore, the bone is the most common
site of BC metastases and their incidence spreads
from 3.6% at 5 years, to 5.9% at 15 years. This can
cause several events, such as bone pain, pathologi-
cal fractures, pancytopenia and, in case of spinal
metastases, cord compression(10). Although MBC is
clinically and epidemiologically similar to FBC,
and its treatment follows the same indication, sur-
vival rates are significantly lower(11-12-13). We report
here the rare case of a MBC metastasizing to the
thoracic spine, treated by posterior decompression
and transpedicle fixation and by a radiofrequency
thermoablation of the lesion. To our knowledge,
there are only eight cases reported in literature,
whose only one treated surgically by vertebroplasty.
In consideration of the very low number of reports,
there are no standardized guidelines for the man-
agement of these lesions.
Case presentation
A 53-years-old male was admitted to our
Neurosurgical unit because of an untreatable dorsal
pain. At the hospitalization, he was presenting a posi-
tive Delitala sign, with pain at pressure on the tho-
racic spine, but no other neurological sign.  He had
been treated 3 years before for breast cancer, for
which reason he had undergone total mastectomy
with axillary lymphadenectomy. Because of this dor-
sal pain, an MRI imaging of the spine was per-
formed. It evidenced pathological masses at T8 level,
attributable to breast cancer metastases (Fig 1).
After the hospitalization, a pre-operative CT
scan confirmed the presence of the metastatic verte-
bral mass and also reported mediastinal involve-
ment. A total body CT scan revealed lungs and liver
metastases. After a multidisciplinary consult, a sur-
gical option was decided to lessen pain and restore
stability to the segmental dorsal spinal unit. During
surgical treatment he underwent posterior T8
decompression and a radiofrequency (RF) electrode
(Vertebral Augmentation System, DFINE) was
introduced into the lytic lesion (Fig 2). The tissue
was heated to about 45°C. A radiofrequency ther-
moablation (MetaSTAR, Dfine, San Jose, USA) in
T8 vertebral body was performed and than followed
by screws and rods fixation (T7-T9) and partial
resection of the mass (Fig 2). Autologous fibrin
glue was used as sealant on the dural plane(14-15-16-17).
Post-operative course was uneventful and the
patient was discharged one week after hospitaliza-
tion with a significant improvement of dorsal pain.
Cycles of adjuvant chemo-radiotherapy followed.
After 8 months, patient is still alive and in good
general conditions, but a spine MRI revealed a
rapid and widespread diffusion of MBC metastases
(Fig 3).  
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Fig 1: Magnetic resonance imaging (MRI): a and b coro-
nal and axial T1-weighted images after gadolinium
administration, showing a neoplastic involvement of T8
vertebral body. c T2-weighted images showing impinge-
ment of the spinal cord. d STIR sequence shows an
osteolytic lesion on T8 vertebral body.
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Fig 2: Magnetic resonance imaging (MRI): a and b T1-
weighted after gadolinium administration and STIR ima-
ges, showing the reduction of volume of T8 vertebral
body, with reduced impingement on the spinal cord. c
and d Computed tomography (CT) scan of the thoracic
spine showing a local posterior decompression and the




Spinal metastases are frequently diagnosed in
case of several malignancies, such as breast, lung,
colon, renal and prostate cancer(18-19), melanoma,
myeloma and lymphoma(20-12). Among these, breast
cancer (BC) metastases are of the most com-
mon(19). In patients with metastatic BC, skeletal
involvement is very frequent, with an incidence of
47-85% in autopsy series, mostly lytic lesions.
Despite the high incidence of BC metastases to the
spine, very few clinical reports in the literature
deal specifically with metastases from MBC,
which is rarer than female counterpart. The ideal
treatment for this cancer requires a multidiscipli-
nary approach(21) and treatments include chemo
and hormonetherapy, radiotherapy and surgery.
The exact indications for surgery, in patients with
advanced metastatic spine disease from BC are
controversial, although it is generally agreed that
the surgery is palliative, not curative(22). To the best
of our knowledge, only 8 cases of MBC spinal
metastases have been reported in literature. Only
in one case an operative treatment was reported: in
that case, the patient had undergone a C3 vertebro-
plasty, in order to treat cervicalgia, and guarantee
pain relief. Percutaneous imaging-guided ablative
therapies using thermal energy sources such as RF,
microwave, laser, and high-intensity focused
sonography have received much recent attention
as minimally invasive strategies for the treatment
of focal malignant diseases(23-24).
The main aim of thermal tumor ablation thera-
py is to destroy a variable quote of tumor by using
heat to kill the malignant cells in a minimally inva-
sive fashion without damaging adjacent vital struc-
tures. Possible advantages include low cost, suit-
ability for real-time imaging guidance, and the abil-
ity to perform ablative procedures on outpatients.
Radiofrequency thermal ablation (RFTA) is consid-
ered the treatment of choice for osteoid osteomas,
in which it has long been safely used. Other benign
conditions (chondroblastoma, osteoblastoma, giant
cell tumor, etc.), can also be treated by this tech-
nique, which is less invasive than traditional surgi-
cal procedures. RFTA ablation is also an option for
the palliation of localized, painful osteolytic
metastatic and myeloma lesions. The reduction in
pain improves the quality of life of patients with
cancer, who often have multiple morbidities and a
limited life expectancy. In some cases, these
patients are treated with RFTA because convention-
al therapies (surgery, radiotherapy, chemotherapy,
etc.) have been exhausted. In other cases, it is com-
bined with conventional therapies or other percuta-
neous treatments, e.g., cementoplasty, offering
faster pain relief and bone strengthening(25-26). In our
case a persistent and untreatable dorsal pain was the
only symptom reported by our patient, thus, after a
multi disciplinary consult, a palliative surgery was
programmed and the thoracic lesion was treated by
decompression, postero-lateral fixation and cobla-
tion of the involved vertebral body followed, after
weeks, by cycles of adjuvant treatment. The prog-
nosis of the MBC is undoubtedly worse of BC in
women. Some researchers justify this by assuming
a different and greater biological aggressiveness(27-28)
but also a average delay in diagnosis of 6 to 10
months since the onset of symptoms maybe for the
rarity of this disease in men and for the low index
of suspicion in both patient and physician. As a
result, the diagnosis in men occurs with greater pro-
gression of the illness(29).
In our case patient a palliative surgery was
performed to lower pain and to restore stability to
the segmental spinal thoracic unit involved by the
tumor. After 8 months, patient is still alive and in
good general conditions but widespread lytic
lesions were observed in a spine MRI. Despite the
poor prognosis of metastasizing BC patients, whose
median survival is about 10 months after the diag-
nosis of spinal involvement, surgery still plays a
role in treating these kind of malignancies and in
improving quality of life(30). Even if systemic thera-
py of bone metastases or locoregional palliative RF
may be useful in treating pain and preventing frac-
tures, early decompressive surgery is proven to be
effective in providing plain relief, neurologic
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Fig 3: Magnetic resonance imaging (MRI): a and b T1-
weighted and STIR images after gadolinium administra-
tion, showing widespread diffusion of osteolytic metasta-
ses.  
improvement, muscle strength maintenance, conti-
nence, and recovery of general conditions(31).
Despite this, there is still not a clear consensus or
evidence based guidelines about the indication both
for surgery and for surgical approach(32). 
To sum up, MBC is a rare neoplasm which
represents <1% of all malignancies in men. It can
metastasize to several sites and mostly spinal
metastases are very rare. Untreatable back-pain can
be the only symptom of spinal involvement, even
with no other neurological signs. In such cases, a
radiological assessment is needed to confirm or dis-
card the hypothesis of metastases or pathological
fracture. In case of spinal metastases from BC,
there is no clear consensus about the operative
treatment; however, our rare case of spinal involve-
ment from advanced male breast cancer demon-
strates that surgery can preserve neurological func-
tions and ensure early pain control, also if in the
short time. Further multicenter and randomized
studies are still needed to confirm the role of the
surgery in case of spinal metastases.
References
1) Weiss J, Moysich K and Swede H. Epidemiology of
male breast cancer. Cancer Epidemiol Biomarkers Prev.
2005; 14: 20-26. 
2) Grasso G, Meli F, Patti R, Giambartino F, Florena AM,
Iacopino DG. Intramedullary spinal cord tumor pre-
senting as the initial manifestation of metastatic colon
cancer: case report and review of the literature. Spinal
Cord. 2007; 45(12): 793-6. 
3) Cicero G, De Luca R, Dorangricchia P, Lo Coco G,
Guarnaccia C, Fanale D, Calò V, Russo A. Risk
Perception and Psychological Distress in Genetic
Counselling for Hereditary Breast and/or Ovarian
Cancer. J Genet Couns. 2017; Mar 10. doi:
10.1007/s10897-017-0072-0. 
4) López-O'Rourke V, Orient-López F, Fontg-Manzano F,
Fernández-Mariscal E, Combalía A, Vilarrasa-Sauquet
R and Sañudo-Martín I. Pathological vertebral com-
pression fracture of C3 due to a breast cancer metasta-
sis in a male patient. Spine. 2009; 34(16): 586-590.
5) La Torre D, Maugeri R, Angileri FF, Pezzino G, Conti
A, Cardali SM, Calisto A, Sciarrone G, Misefari A,
Germanò A, Tomasello F. Human leukocyte antigen
frequency in human high-grade gliomas: a case-control
study in Sicily. Neurosurgery. 2009; 64(6):1082-8. 
6) Maugeri R, Schiera G, Di Liegro CM, Fricano A,
Iacopino DG, Di Liegro I. Aquaporins and Brain
Tumors. Int J Mol Sci. 2016; 17(7): 1029. 
7) Botelho R, Oliveira M and Rotta J. Quantification of
vertebral involvement in metastatic spinal disease.
Open Orthop J, 2013; 7(7): 286-291.
8) Oliveira M, Rotta J and Botelho R. Survival analysis in
patients with metastatic spinal disease: the influence of
surgery, histology, clinical and neurologic status. Arq
Neuropsiquiatr. 2015; 73(4):330-335
9) De Luca R, Venezia R, Caputo V, Dorangricchia P,
Bavetta D Cicero G. Impact Of Combination
Chemotherapy On Toxicity In Ovarian Cancer:
Systematic Revision Of Literature And Meta-Analysis.
Acta Medica Mediterranea. 2016; 32:1835-42.
10) Fontanella C, Fanotto V, Rihawi K, Aprile G and
Puglisi F. Skeletal metastases from breast cancer:
pathogenesis of bone tropism and treatment strategy.
Clin Exp Metastasis. 2015; 32:819-833.
11) Sanguinetti A, Polistena A, Lucchini R, Monacelli M,
Galasse S, Avenia S, Triola R, Bugiantella W, Cirocchi
R, Rondelli F and Avenia N. Male breast cancer, clini-
cal presentation, diagnosis and treatment: twenty years
of experience in our breast unit. Int J Surg Case Rep.
2016; 20: 8-11.
12) Meraviglia S, La Mendola C, Orlando V, Scarpa F,
Cicero G, Dieli F. Vg9Vd2 T cells as a promising inno-
vative tool for immunotherapy of hematologic malig-
nancies. Oncology Reviews. 2010; 4(4): 211-218. 
13) Meraviglia S, Eberl M, Vermijlen D, Todaro M,
Buccheri S, Cicero G, La Mendola C, Guggino G,
D'Asaro M, Orlando V, Scarpa F, Roberts A, Caccamo
N, Stassi G, Dieli F, Hayday AC. In vivo manipulation
of V9V2 T cells with zoledronate and low-dose inter-
leukin-2 for immunotherapy of advanced breast cancer
patients. Clinical and Experimental Immunology. 2010;
161(2): 290-297.
14) Graziano F, Maugeri R, Basile L, Meccio F, Iacopino
DG. Aulogous fibrin sealant (Vivostat(®)) in the neuro-
surgical practice: Part II: Vertebro-spinal procedures.
Surg Neurol Int. 2016;7(3): 77-82. 
15) Korde LA, Zujewski JA, Kamin L, Giordano S,
Domchek S, Anderson WF, Bartlett JM, Gelmon K,
Nahleh Z, Bergh J, Cutuli B, Pruneri G, McCaskill-
Stevens W, Gralow J, Hortobagyi G, Cardoso F.
Multidisciplinary meeting on male breast cancer: sum-
mary and research recommendations. J Clin Oncol.
2010;28(12):2114-22.
16) Maugeri R, Basile L, Giugno A, Graziano F, Iacopino
DG. Impasse in the management of recurrent basal cell
carcinoma of the skull with sagittal sinus erosion.
Interdisciplinary Neurosurgery. 2015; 2(3): 160-163.
17) Maugeri R, Giammalva GR, Graziano F and Iacopino
DG. May autologue fibrin glue alone enhance ossifica-
tion? An unexpected spinal fusion. World Neurosurg.
2016; 95: 611-612.
18) Cicero G, De Luca R, Dorangricchia P, Dieli F. The
Clinical Efficacy of Enzalutamide in Metastatic
Prostate Cancer: Prospective Single-center Study.
Anticancer Res. 2017; 37(3): 1475-1480.
19) Cicero G, De Luca R, Dorangricchia P, Galvano A, Lo
Re G, Serretta V, Dispensa N, Dieli F. Cabazitaxel in
Metastatic Castration-Resistant Prostate Cancer
Patients Progressing after Docetaxel: A Prospective
Single-Center Study.Oncology. 2017; 92(2): 94-100. 
20) Kuba S, Ishida M, Oikawa M, Nakamura Y,
Yamanouchi K, Tokunaga E, Taguchi K, Esaki T,
Eguchi S and Ohno S. Aromatase inhibitors with or
without luteinizing hormone-releasing hormone agonist
for metastatic male breast cancer: report of four cases
and review of the literature. Breast Cancer. 2016;
23(6): 945-949.  
1160 Rosario Maugeri, Giuseppe Roberto Giammalva et Al
21) De Luca R, Dorangricchia P, Guarnaccia C, Lo Coco G
Cicero G. The Patient-Physician Relationship In The
Face Of Oncological Disease: A Review Of Literature
On The Emotional And Psychological Reactions Of
Patients And Physician. Acta Medica Mediterranea.
2016; 32: 1827-33.
22) Shehadi J, Sciubba D, Suk I, Suki D, Maldaun M,
McCutcheon I, Nader R, Theriault R, Rhines L and
Gokaslan Z. Surgical treatment strategies and outcome
in patients with breast cancer metastatic to the spine: a
review of 87 patients. Eur Spine J. 2007; (16): 1179-
1192.
23) Berman A, Thukral A, Hwang W, Solin L and Vapiwala
N. Incidence and patterns of distant metastases for
patient with early-stage breast cancer after breast con-
servation treatment. Clin Breast Cancer. 2013; 13(2):
88-94.
24) Choi D, Crockard A, Bunger CHarms J, Kawahara N,
Mazel C, Melcher R and Tomita K. Review of metasta-
tic spine tumour classification and indications for
surgery: the consensus statement of the Global Spine
Tumour Study Group. Eur Spine J. 2010; (19): 215-
222. 
25) Maugeri R, Graziano F, Basile L, Gulì C, Giugno A,
Giammalva GR, Visocchi M, Iacopino DG.
Reconstruction of Vertebral Body After
Radiofrequency Ablation and Augmentation in
Dorsolumbar Metastatic Vertebral Fracture: Analysis of
Clinical and Radiological Outcome in a Clinical Series
of 18 Patients. Acta Neurochir Suppl. 2017; (124): 81-
86.
26) Caccamo N, Meraviglia S, Cicero G, Gulotta, G,
Moschella F, Cordova A, Gulotta E, Salerno A, Dieli F.
Aminobisphosphonates as New Weapons for
gammaDelta T Cell-Based Immunotherapy of Cancer.
Current Medical Chemistry. 2008; 15(12): 1147-1153.
27) Grenader T and Shavit L. Synchronous male breast
cancer and carcinoma of prostate in 90-year-old male,
presented with spinal cord compression and multiple
spine lytic lesions. Breast J. 2017; 13(4): 410-412.
28) Dieli F, Vermijlen D, Fulfaro F, Caccamo NR,
Meraviglia S, Cicero G, Roberts A, Buccheri S, D'asaro
M, Gebbia N, Salerno A, Eberl M, Hayday AC.
Targeting human γδ T cells with zoledronate and inter-
leukin-2 for immunotherapy of hormone-refractory
prostate cancer. Cancer Research. 2007; 67(15): 7450-
7457.
29) Tokuhashi Y, Matsuzaki H, Oda H, Oshima M and Ryu
J. A revised scoring system for preoperative evaluation
of metastatic spine tumor prognosis. Spine. 2005;
30(19): 2186-2191. 
30) De Souza P, De Rezende Pinto W and Santos A.
Metastatic breast cancer in a man with nonprogressive
ataxia and epilepsy. Neurology. 2015; 85(13): 1183-
1184.
31) Fontanella C, Fanotto V, Rihawi K, Aprile G and
Puglisi F. Skeletal metastases from breast cancer:
pathogenesis of bone tropism and treatment strategy.
Clin Exp Metastasis.2015; 32: 819-833.
32) Tomita K, Kawahara N, Kobayashi T, Yoshida A,
Murakami H and Akamaru T. Surgical strategy for
spinal metastases. Spine. 2001; 26: 298-306.
_________
Corresponding author
Prof. GIUSEPPE CICERO, MD, PhD
Department of Surgical, Oncological and Oral Sciences, 
University of Palermo, Medical Oncology 
Via del Vespro 129
90127 Palermo
(Italy)
Unusual case of dorsal vertebral metastases from a male breast cancer        1161
